NFKB1 and melanoma: As described, ROS enhances the signal transduction pathways of NF-κB and, since melanoma is a human cancer with a constitutive oxidative stress status, unsurprisingly, as in another human tumor, the activation of NF-κB is unambiguously considered a hallmark of tumor development and progression.